Amgen Inc. (AMGN)

USD 258.78

(-2.7%)

Revenue Summary of Amgen Inc.

  • Amgen Inc.'s latest annual revenue in 2023 was 28.19 Billion USD , up 7.09% from previous year.
  • Amgen Inc.'s latest quarterly revenue in 2024 Q3 was 8.5 Billion USD , up 2.04% from previous quarter.
  • Amgen Inc. reported a annual revenue of 26.32 Billion USD in annual revenue 2022, up 1.32% from previous year.
  • Amgen Inc. reported a annual revenue of 25.97 Billion USD in annual revenue 2021, up 2.18% from previous year.
  • Amgen Inc. reported a quarterly revenue of 8.33 Billion USD for 2024 Q2, up 12.67% from previous quarter.
  • Amgen Inc. reported a quarterly revenue of 8.5 Billion USD for 2024 Q3, up 2.04% from previous quarter.

Annual Revenue Chart of Amgen Inc. (2023 - 1990)

Historical Annual Revenue of Amgen Inc. (2023 - 1990)

Year Revenue Revenue Growth
2023 28.19 Billion USD 7.09%
2022 26.32 Billion USD 1.32%
2021 25.97 Billion USD 2.18%
2020 25.42 Billion USD 8.83%
2019 23.36 Billion USD -1.62%
2018 23.74 Billion USD 3.93%
2017 22.84 Billion USD -0.62%
2016 22.99 Billion USD 6.14%
2015 21.66 Billion USD 7.97%
2014 20.06 Billion USD 7.43%
2013 18.67 Billion USD 8.17%
2012 17.26 Billion USD 10.8%
2011 15.58 Billion USD 3.51%
2010 15.05 Billion USD 2.81%
2009 14.64 Billion USD -2.41%
2008 15 Billion USD 1.57%
2007 14.77 Billion USD 3.53%
2006 14.26 Billion USD 14.79%
2005 12.43 Billion USD 17.82%
2004 10.55 Billion USD 26.26%
2003 8.35 Billion USD 51.29%
2002 5.52 Billion USD 37.54%
2001 4.01 Billion USD 16.45%
2000 3.44 Billion USD 7.62%
1999 3.2 Billion USD 21.27%
1998 2.64 Billion USD 12.64%
1997 2.34 Billion USD 6.71%
1996 2.19 Billion USD 15.46%
1995 1.9 Billion USD 17.52%
1994 1.62 Billion USD 19.57%
1993 1.35 Billion USD 25.42%
1992 1.08 Billion USD 58.91%
1991 679.8 Million USD 257.04%
1990 190.4 Million USD 0.0%

Peer Revenue Comparison of Amgen Inc.

Name Revenue Revenue Difference
AstraZeneca PLC 45.81 Billion USD 38.465%
Biogen Inc. 9.83 Billion USD -186.612%
Gilead Sciences, Inc. 27.11 Billion USD -3.961%
MIRA Pharmaceuticals, Inc. - USD -Infinity%
Scilex Holding Company 46.74 Million USD -60208.495%
Scilex Holding Company 46.74 Million USD -60208.495%